News Focus
News Focus
icon url

Pharmboy46

03/29/25 8:26 AM

#757133 RE: flipper44 #757132

I would hope and reason that most people diagnosed with a GBM would seek a knowledgeable physician- be it a neurosurgeon or oncologist who hopefully will recommend the necessary steps to keep the tumor and apply to the specials program to receive DCVax??
icon url

Investor082

03/29/25 9:00 AM

#757145 RE: flipper44 #757132

BS and excuses! JAMA was going to change that and so was TLD. What happened to that?

No one was stopping them from running multiple combination trials or upgrade manufacturing. They have always played a victim card and will continue to do so post UK approval. The lying and lethargic management crew will not change their behavior. There wont be any non dilutive cash injection from big pharma and therefore situation ain’t changing post UK approval.

Continue with blame games and excuses though! How about LG’s lies from 4.5 years ago? Why would any patient’s and their families trust such lying crew?
icon url

XMaster2023

03/29/25 10:59 AM

#757158 RE: flipper44 #757132

Neurosurgeons are also well aware (they were part of the trial and know the results) of DCVax-L. and after approval in the UK some Neurosurgeons will advise some of their patients to freeze their tumor and have it shipped to the UK to create the vaccine. Some patients who do have the bandwidth will ask for the vaccine.
Approval will ring in a new era of technology.
icon url

iclight

03/29/25 3:50 PM

#757193 RE: flipper44 #757132

Oncologists understand that it doesn’t work. Ask Bayh who was literally on the board and didn’t choose DCvax when she got GBM.

People who get GBM aren’t locked in boxes. They have friends and family who can research, not to mention their own oncologists, yet the Specials program gets what, 4 people a year of that. Changing the endpoints because the data sucked is a red flag.